Related Experiment Video
Updated: Jun 14, 2025

An Operant Intra-/Extra-dimensional Set-shift Task for Mice
Published on: January 22, 2016
Executive functions in psychopathy: a meta-analysis of inhibition, planning, shifting, and working memory performance
Matthias Burghart1,2, Sergej Schmidt1, Daniela Mier1
1Department of Psychology, University of Konstanz, Konstanz, Germany.
Abstract:
Much research has focused on executive function (EF) impairments in psychopathy, a severe personality disorder characterized by a lack of empathy, antisocial behavior, and a disregard for social norms and moral values. However, it is still unclear to what extent EF deficits are present across psychopathy factors and, more importantly, which EF domains are impaired. The current meta-analysis answers these questions by synthesizing the results of 50 studies involving 5,694 participants from 12 different countries. Using multilevel random-effects models, we pooled effect sizes (Cohen's d) for five different EF domains: overall EF, inhibition, planning, shifting, and working memory. Moreover, differences between psychopathy factors were evaluated. Our analyses revealed small deficits in overall EF, inhibition, and planning performance. However, a closer inspection of psychopathy factors indicated that EF deficits were specific to lifestyle/antisocial traits, such as disinhibition. Conversely, interpersonal/affective traits, such as boldness, showed no deficits and in some cases even improved EF performance. These findings suggest that EF deficits are not a key feature of psychopathy per se, but rather are related to antisociality and disinhibitory traits. Potential brain correlates of these findings as well as implications for future research and treatment are discussed.
Related Concept Videos
Information Processing Approach
Working Memory
Role of Cerebellum and Prefrontal Cortex in Memory
High-Level and Low-Level Awareness
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

